ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

SYRS Syros Pharmaceuticals Inc

5.00
0.00 (0.00%)
Pre Mercado
Última actualización: 06:24:20
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Syros Pharmaceuticals Inc SYRS NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.00 0.00% 5.00 06:24:20
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
5.00
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
14/5/202406:30BWSyros Reports First Quarter 2024 Financial Results and..
14/5/202405:42EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/5/202408:00BWSyros to Participate in Upcoming Investor Conferences
07/5/202406:00BWSyros to Report First Quarter 2024 Financial Results on..
09/4/202406:00BWSyros Receives Fast Track Designation from the FDA for..
02/4/202415:30BWSyros Reports Inducement Grants Under Nasdaq Listing Rule..
27/3/202406:30BWSyros Reports Fourth Quarter and Full Year 2023 Financial..
27/3/202405:57IHMARKETNEWSU.S. Stock Index Futures Point to a Rebound, Oil See..
25/3/202406:00BWSyros Announces Completion of Enrollment of 190 Patients..
20/3/202406:00BWSyros to Report Fourth Quarter and Full Year 2023 Financial..
27/2/202406:00BWSyros to Participate in TD Cowen 44th Annual Health Care..
14/2/202419:56EDGAR2Form SC 13G - Statement of acquisition of beneficial..
13/2/202419:22EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202418:02EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202417:59EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/1/202406:06EDGAR2Form 8-K - Current report
08/1/202406:00BWSyros Highlights Anticipated 2024 Milestones to Deliver on..
02/1/202415:15EDGAR2Form SC 13G - Statement of acquisition of beneficial..
26/12/202316:19EDGAR2Form SC 13D/A - General statement of acquisition of..
19/12/202315:59EDGAR2Form 8-K - Current report
19/12/202315:53EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
19/12/202306:27BWSyros Announces Pricing of $45.0 million Underwritten..
14/12/202315:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202315:12EDGAR2Form 144 - Report of proposed sale of securities
08/12/202315:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202315:00EDGAR2Form 144 - Report of proposed sale of securities
06/12/202306:05EDGAR2Form 8-K - Current report
06/12/202306:00BWSyros Announces Encouraging Initial Data from Randomized..
05/12/202316:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202306:30BWSyros to Participate in Upcoming Investor Conferences
14/11/202306:30BWSyros Reports Third Quarter 2023 Financial Results and..
14/11/202305:47EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202306:30BWSyros to Report Third Quarter 2023 Financial Results on..
02/11/202315:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/11/202315:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/11/202315:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/11/202315:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/10/202315:15EDGAR2Form SC 13D - General statement of acquisition of beneficial..
02/10/202307:49EDGAR2Form 8-K - Current report
02/10/202307:45BWSyros Announces Planned CEO Leadership Transition and..
07/9/202315:30BWSyros Reports Inducement Grants Under Nasdaq Listing Rule..
11/8/202315:30EDGAR2Form 8-K - Current report
08/8/202306:30BWSyros Reports Second Quarter 2023 Financial Results and..
08/8/202305:53EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
04/8/202315:30BWSyros Reports Inducement Grants Under Nasdaq Listing Rule..
02/8/202315:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/8/202306:30BWSyros to Report Second Quarter 2023 Financial Results on..
31/7/202315:12EDGAR2Form 144 - Report of proposed sale of securities
21/7/202315:36EDGAR2Form 8-K - Current report
18/7/202319:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..